Hepatocellular carcinoma risk factors: Difference between revisions

	Hepatocellular carcinoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes of Hepatocellular carcinoma
Differentiating Hepatocellular carcinoma from other Diseases
Epidemiology & Demographics
Risk Factors
Screening
Natural History, Complications & Prognosis
Diagnosis
Diagnostic study of choice
History and symptoms
Physical Examination
Lab Tests
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hepatocellular carcinoma risk factors On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hepatocellular carcinoma risk factors All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hepatocellular carcinoma risk factors
CDC on Hepatocellular carcinoma risk factors
Hepatocellular carcinoma risk factors in the news
Blogs on Hepatocellular carcinoma risk factors
Directions to Hospitals Treating Hepatocellular carcinoma
Risk calculators and risk factors for Hepatocellular carcinoma risk factors

VisualWikitext

Revision as of 17:44, 19 January 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2] Mohamad Alkateb, MBBCh [3]

Overview

Common risk factors in the development of hepatocellular carcinoma are chronic hepatitis B infection, chronic hepatitis C infection, cirrhosis, inherited metabolic diseases and aflaoxins.

Common Risk Factors

Common risk factors that may increase the risk of developing hepatocellular carcinoma are:^[1]^[2]^[3]^[4]^[5]

Chronic hepatitis B
Chronic hepatitis C
Cirrhosis with hemochromatosis
Nonalcoholic steatohepatitis
Food icontaminated with Aspergillus flavus (especially peanuts and corns stored during prolonged wet seasons), which produces aflatoxins.

Less Common Risk Factors

Less common risk factors that may increase the risk of developing hepatocellular carcinoma are:^[6]^[7]^[8]

Anabolic steroids
Alpha1-antitrypsin deficiency
Arsenic
Alcohol
Obesity
Diabetes Mellitus
Food infected with Aspergillus flavus (especially peanuts and corns stored during prolonged wet seasons), which produces aflatoxin.
Glycogen storage diseases
Hemochromatosis
Inherited metabolic diseases such as:
- Porphyria cutanea tarda
Smoking
Tyrosinemia
Vinyl chloride and thorium dioxide
Wilson disease

References

↑ National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/liver/hp/adult-liver-treatment-pdq
↑ Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, Jenab M, Pischon T, Nöthlings U, Overved K, Tjønneland A, Outzen M, Clavel-Chapelon F, Kaaks R, Lukanova A, Boeing H, Aleksandrova K, Benetou V, Zylis D, Palli D, Pala V, Panico S, Tumino R, Sacerdote C, Bueno-De-Mesquita HB, Van Kranen HJ, Peeters PH, Lund E, Quirós JR, González CA, Sanchez Perez MJ, Navarro C, Dorronsoro M, Barricarte A, Lindkvist B, Regnér S, Werner M, Hallmans G, Khaw KT, Wareham N, Key T, Romieu I, Chuang SC, Murphy N, Boffetta P, Trichopoulou A, Riboli E (2011). "Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study". J. Natl. Cancer Inst. 103 (22): 1686–95. doi:10.1093/jnci/djr395. PMC 3216968. PMID 22021666.
↑ Cecil, Russell L., James B. Wyngaarden, and Lloyd H. Smith. Textbook of . Philadelphia: Saunders, 1988. Print.
↑ "Redirecting".
↑ CHEDID, Marcio F.; KRUEL, Cleber R. P.; PINTO, Marcelo A.; GREZZANA-FILHO, Tomaz J. M.; LEIPNITZ, Ian; KRUEL, Cleber D. P.; SCAFFARO, Leandro A.; CHEDID, Aljamir D. (2017). "HEPATOCELLULAR CARCINOMA: DIAGNOSIS AND OPERATIVE MANAGEMENT". ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 30 (4): 272–278. doi:10.1590/0102-6720201700040011. ISSN 2317-6326.
↑ Clavière C, Bronowicki JP, Hudziak H, Bigard MA, Gaucher P (1998). "[Role of sex steroids and their receptors in the pathophysiology of hepatocellular carcinoma]". Gastroenterol. Clin. Biol. (in French). 22 (1): 73–86. PMID 9762169.
↑ "Studies of Cancer in Humans - Tobacco Smoke and Involuntary Smoking - NCBI Bookshelf".
↑ "Tobacco smoke and involuntary smoking". IARC Monogr Eval Carcinog Risks Hum. 83: 1–1438. 2004. PMC 4781536. PMID 15285078.

Template:WikiDoc Sources

[cancergov-1] National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/liver/hp/adult-liver-treatment-pdq

[pmid22021666-2] Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, Jenab M, Pischon T, Nöthlings U, Overved K, Tjønneland A, Outzen M, Clavel-Chapelon F, Kaaks R, Lukanova A, Boeing H, Aleksandrova K, Benetou V, Zylis D, Palli D, Pala V, Panico S, Tumino R, Sacerdote C, Bueno-De-Mesquita HB, Van Kranen HJ, Peeters PH, Lund E, Quirós JR, González CA, Sanchez Perez MJ, Navarro C, Dorronsoro M, Barricarte A, Lindkvist B, Regnér S, Werner M, Hallmans G, Khaw KT, Wareham N, Key T, Romieu I, Chuang SC, Murphy N, Boffetta P, Trichopoulou A, Riboli E (2011). "Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study". J. Natl. Cancer Inst. 103 (22): 1686–95. doi:10.1093/jnci/djr395. PMC 3216968. PMID 22021666.

[3] Cecil, Russell L., James B. Wyngaarden, and Lloyd H. Smith. Textbook of . Philadelphia: Saunders, 1988. Print.

[urlRedirecting-4] "Redirecting".

[CHEDIDKRUEL2017-5] CHEDID, Marcio F.; KRUEL, Cleber R. P.; PINTO, Marcelo A.; GREZZANA-FILHO, Tomaz J. M.; LEIPNITZ, Ian; KRUEL, Cleber D. P.; SCAFFARO, Leandro A.; CHEDID, Aljamir D. (2017). "HEPATOCELLULAR CARCINOMA: DIAGNOSIS AND OPERATIVE MANAGEMENT". ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 30 (4): 272–278. doi:10.1590/0102-6720201700040011. ISSN 2317-6326.

[pmid9762169-6] Clavière C, Bronowicki JP, Hudziak H, Bigard MA, Gaucher P (1998). "[Role of sex steroids and their receptors in the pathophysiology of hepatocellular carcinoma]". Gastroenterol. Clin. Biol. (in French). 22 (1): 73–86. PMID 9762169.

[urlStudies_of_Cancer_in_Humans_-_Tobacco_Smoke_and_Involuntary_Smoking_-_NCBI_Bookshelf-7] "Studies of Cancer in Humans - Tobacco Smoke and Involuntary Smoking - NCBI Bookshelf".

[pmid15285078-8] "Tobacco smoke and involuntary smoking". IARC Monogr Eval Carcinog Risks Hum. 83: 1–1438. 2004. PMC 4781536. PMID 15285078.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

@@ Line 8: / Line 8: @@
 ==Common Risk Factors==
-Common [[risk factors]] that may increase the risk of developing hepatocellular carcinoma are:<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/liver/hp/adult-liver-treatment-pdq</ref><ref name="pmid22021666">{{cite journal |vauthors=Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, Jenab M, Pischon T, Nöthlings U, Overved K, Tjønneland A, Outzen M, Clavel-Chapelon F, Kaaks R, Lukanova A, Boeing H, Aleksandrova K, Benetou V, Zylis D, Palli D, Pala V, Panico S, Tumino R, Sacerdote C, Bueno-De-Mesquita HB, Van Kranen HJ, Peeters PH, Lund E, Quirós JR, González CA, Sanchez Perez MJ, Navarro C, Dorronsoro M, Barricarte A, Lindkvist B, Regnér S, Werner M, Hallmans G, Khaw KT, Wareham N, Key T, Romieu I, Chuang SC, Murphy N, Boffetta P, Trichopoulou A, Riboli E |title=Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study |journal=J. Natl. Cancer Inst. |volume=103 |issue=22 |pages=1686–95 |year=2011 |pmid=22021666 |pmc=3216968 |doi=10.1093/jnci/djr395 |url=}}</ref><ref>Cecil, Russell L., James B. Wyngaarden, and Lloyd H. Smith. ''Textbook of ''. Philadelphia: Saunders, 1988. Print.</ref><ref name="urlRedirecting">{{cite web |url=https://doi.org/10.1053/j.gastro.2004.09.010 |title=Redirecting |format= |work= |accessdate=}}</ref>
+Common [[risk factors]] that may increase the risk of developing hepatocellular carcinoma are:<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/liver/hp/adult-liver-treatment-pdq</ref><ref name="pmid22021666">{{cite journal |vauthors=Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, Jenab M, Pischon T, Nöthlings U, Overved K, Tjønneland A, Outzen M, Clavel-Chapelon F, Kaaks R, Lukanova A, Boeing H, Aleksandrova K, Benetou V, Zylis D, Palli D, Pala V, Panico S, Tumino R, Sacerdote C, Bueno-De-Mesquita HB, Van Kranen HJ, Peeters PH, Lund E, Quirós JR, González CA, Sanchez Perez MJ, Navarro C, Dorronsoro M, Barricarte A, Lindkvist B, Regnér S, Werner M, Hallmans G, Khaw KT, Wareham N, Key T, Romieu I, Chuang SC, Murphy N, Boffetta P, Trichopoulou A, Riboli E |title=Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study |journal=J. Natl. Cancer Inst. |volume=103 |issue=22 |pages=1686–95 |year=2011 |pmid=22021666 |pmc=3216968 |doi=10.1093/jnci/djr395 |url=}}</ref><ref>Cecil, Russell L., James B. Wyngaarden, and Lloyd H. Smith. ''Textbook of ''. Philadelphia: Saunders, 1988. Print.</ref><ref name="urlRedirecting">{{cite web |url=https://doi.org/10.1053/j.gastro.2004.09.010 |title=Redirecting |format= |work= |accessdate=}}</ref><ref name="CHEDIDKRUEL2017">{{cite journal|last1=CHEDID|first1=Marcio F.|last2=KRUEL|first2=Cleber R. P.|last3=PINTO|first3=Marcelo A.|last4=GREZZANA-FILHO|first4=Tomaz J. M.|last5=LEIPNITZ|first5=Ian|last6=KRUEL|first6=Cleber D. P.|last7=SCAFFARO|first7=Leandro A.|last8=CHEDID|first8=Aljamir D.|title=HEPATOCELLULAR CARCINOMA: DIAGNOSIS AND OPERATIVE MANAGEMENT|journal=ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)|volume=30|issue=4|year=2017|pages=272–278|issn=2317-6326|doi=10.1590/0102-6720201700040011}}</ref>
 *[[Chronic hepatitis B]]
 *[[Chronic hepatitis C]]